[HTML] cell.comFull View

[HTML][HTML] Mitigating the risk of antimalarial resistance via covalent dual-subunit inhibition of the Plasmodium proteasome

I Deni, BH Stokes, KE Ward, KJ Fairhurst… - Cell chemical …, 2023 - cell.com
The Plasmodium falciparum proteasome constitutes a promising antimalarial target, with
multiple chemotypes potently and selectively inhibiting parasite proliferation and synergizing …
被引用次数：11 相关文章
[HTML] nih.gov

[HTML][HTML] Mitigating the risk of antimalarial resistance via covalent dual-subunit inhibition of the Plasmodium proteasome

I Deni, BH Stokes, KE Ward, KJ Fairhurst… - Cell Chemical …, 2023 - ncbi.nlm.nih.gov
The Plasmodium falciparum proteasome constitutes a promising antimalarial target, with
multiple chemotypes potently and selectively inhibiting parasite proliferation and synergizing …

Mitigating the risk of antimalarial resistance via covalent dual-subunit inhibition of the Plasmodium proteasome.

I Deni, BH Stokes, KE Ward, KJ Fairhurst… - Cell Chemical …, 2023 - europepmc.org
The Plasmodium falciparum proteasome constitutes a promising antimalarial target, with
multiple chemotypes potently and selectively inhibiting parasite proliferation and synergizing …
[HTML] sciencedirect.com

[HTML][HTML] Mitigating the risk of antimalarial resistance via covalent dual-subunit inhibition of the Plasmodium proteasome

I Deni, BH Stokes, KE Ward, KJ Fairhurst… - Cell Chemical …, 2023 - Elsevier
The Plasmodium falciparum proteasome constitutes a promising antimalarial target, with
multiple chemotypes potently and selectively inhibiting parasite proliferation and synergizing …
[PDF] stanford.edu

[PDF][PDF] Mitigating the risk of antimalarial resistance via covalent dual-subunit inhibition of the Plasmodium proteasome

I Deni, BH Stokes, KE Ward, KJ Fairhurst… - Cell Chemical …, 2023 - med.stanford.edu
The Plasmodium falciparum proteasome constitutes a promising antimalarial target, with
multiple chemotypes potently and selectively inhibiting parasite proliferation and synergizing …

Mitigating the risk of antimalarial resistance via covalent dual-subunit inhibition of the Plasmodium proteasome

I Deni, BH Stokes, KE Ward… - Cell chemical …, 2023 - pubmed.ncbi.nlm.nih.gov
The Plasmodium falciparum proteasome constitutes a promising antimalarial target, with
multiple chemotypes potently and selectively inhibiting parasite proliferation and synergizing …

Mitigating the risk of antimalarial resistance via covalent dual-subunit inhibition of the Plasmodium proteasome.

I Deni, BH Stokes, KE Ward, KJ Fairhurst, CFA Pasaje… - 2023 - cabidigitallibrary.org
The Plasmodium falciparum proteasome constitutes a promising antimalarial target, with
multiple chemotypes potently and selectively inhibiting parasite proliferation and synergizing …

Mitigating the risk of antimalarial resistance via covalent dual-subunit inhibition of the Plasmodium proteasome

I Deni, BH Stokes, KE Ward, KJ Fairhurst… - Cell Chemical …, 2023 - experts.nebraska.edu
The Plasmodium falciparum proteasome constitutes a promising antimalarial target, with
multiple chemotypes potently and selectively inhibiting parasite proliferation and synergizing …
[PDF] malariaworld.org

[PDF][PDF] Mitigating the risk of antimalarial resistance via covalent dual-subunit inhibition of the Plasmodium proteasome

I Deni, BH Stokes, KE Ward, KJ Fairhurst… - Cell Chemical …, 2023 - media.malariaworld.org
The Plasmodium falciparum proteasome constitutes a promising antimalarial target, with
multiple chemotypes potently and selectively inhibiting parasite proliferation and synergizing …

Mitigating the risk of antimalarial resistance via covalent dual-subunit inhibition of the Plasmodium proteasome.

I Deni, BH Stokes, KE Ward, KJ Fairhurst… - Cell Chemical …, 2023 - europepmc.org
The Plasmodium falciparum proteasome constitutes a promising antimalarial target, with
multiple chemotypes potently and selectively inhibiting parasite proliferation and synergizing …